NCT06140095View on ClinicalTrials.gov

Studies to Gain Insight How the Drugs PCSK9-inhibitors and Statins Affect Cholesterol and Bile Acid Metabolism

EARLY_PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

February 29, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Acute Metabolic Effects of Evolocumab and Atorvastatin
Interventions
DRUG

Evolocumab

See arm description

Sponsors

Collaborators (1)

Amgen
All Listed Sponsors
collaborator

Amgen

INDUSTRY

lead

Region Stockholm

OTHER_GOV